PARP1 and prostate carcinoma: As shown from the figure, PARP1 (cluster 1) was found to have conditional essentiality with cell lines having mutation in CHEK2 (cluster 3) and a survival advantage of down regulation of PARP1 in prostate cancer patients when CHEK2 was mutated.